Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia

Journal of Molecular and Cellular Cardiology

Volumn 93, Issue , 2016, Pages 18-31

  Ren, Jun ^a,b   Xu, Xihui ^b   Wang, Qiurong ^b   Ren, Sidney Y ^b   Dong, Maolong ^b,c   Zhang, Yingmei ^a,b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Apoptosis; Autophagy; Cardiac function; Endotoxemia; Inflammation

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADIPONECTIN; BECLIN 1; CASPASE 3; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B; INTERLEUKIN 1BETA; LC3B PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MARKER; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P62; RAPAMYCIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; UNCOORDINATED 51 LIKE KINASE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; LIPOPOLYSACCHARIDE; RIBONUCLEOTIDE; SERINE THREONINE PROTEIN KINASE ULK1; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CALCIUM CELL LEVEL; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FRACTIONAL SHORTENING; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART VENTRICLE REMODELING; LEFT VENTRICULAR ENDSYSTOLIC DIAMETER; LIPOPOLYSACCHARIDE-INDUCED ENDOTOXEMIA; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL DEATH; COMPLICATION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; ENDOTOXEMIA; GENETICS; HEART VENTRICLE FUNCTION; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ADIPONECTIN; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEIN-1 HOMOLOG; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELL DEATH; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; MYOCARDITIS; MYOCARDIUM; MYOCYTES, CARDIAC; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES; VENTRICULAR DYSFUNCTION;

EID: 84961136544     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.02.002     Document Type: Article

References (66)

1. Puskarich M.A., Trzeciak S., Shapiro N.I., Arnold R.C., Horton J.M., Studnek J.R., et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit. Care Med. 2011, 39:2066-2071.
2. Bentzer P., Russell J.A., Walley K.R. Advances in sepsis research. Clin. Chest Med. 2015, 36:521-530.
3. Ren J., Wu S. A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction. Front. Biosci. 2006, 11:15-22.
4. Seymour C.W., Rosengart M.R. Septic shock: advances in diagnosis and treatment. J. Am. Med. Assoc. 2015, 314:708-717.
5. Ceylan-Isik A.F., Zhao P., Zhang B., Xiao X., Su G., Ren J. Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis. J. Mol. Cell. Cardiol. 2010, 48:367-378.
6. Turdi S., Han X., Huff A.F., Roe N.D., Hu N., Gao F., et al. Cardiac-specific overexpression of catalase attenuates lipopolysaccharide-induced myocardial contractile dysfunction: role of autophagy. Free Radic. Biol. Med. 2012, 53:1327-1338.
7. Zhang Y., Xu X., Ceylan-Isik A.F., Dong M., Pei Z., Li Y., et al. Ablation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: role of Akt ubiquitination E3 ligase TRAF6. J. Mol. Cell. Cardiol. 2014, 74C:76-87.
8. Fry D.E. Sepsis, systemic inflammatory response, and multiple organ dysfunction: The mystery continues. Am. Surg. 2012, 78:1-8.
9. Guo R., Zhang Y., Turdi S., Ren J. Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy. Biochim. Biophys. Acta 1832, 2013:1136-1148.
10. Matsuzawa Y., Funahashi T., Kihara S., Shimomura I. Adiponectin and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2004, 24:29-33.
11. Ding G., Qin Q., He N., Francis-David S.C., Hou J., Liu J., et al. Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J. Mol. Cell. Cardiol. 2007, 43:73-84.
12. Pineiro R., Iglesias M.J., Gallego R., Raghay K., Eiras S., Rubio J., et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 2005, 579:5163-5169.
13. Caselli C., D'Amico A., Cabiati M., Prescimone T., Del Ry S., Giannessi D. Back to the heart: the protective role of adiponectin. Pharmacol. Res. 2014, 82:9-20.
14. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006, 116:1784-1792.
15. Shibata R., Ouchi N., Kihara S., Sato K., Funahashi T., Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J. Biol. Chem. 2004, 279:28670-28674.
16. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 2004, 10:1384-1389.
17. Uji Y., Yamamoto H., Maeda K., Tsuchihashi H., Akabori H., Shimizu T., et al. Adiponectin deficiency promotes the production of inflammatory mediators while severely exacerbating hepatic injury in mice with polymicrobial sepsis. J. Surg. Res. 2010, 161:301-311.
18. Cai L., Yi F., Dai Z., Huang X., Zhao Y.D., Mirza M.K., et al. Loss of caveolin-1 and adiponectin induces severe inflammatory lung injury following LPS challenge through excessive oxidative/nitrative stress. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 306:L566-L573.
19. Watanabe Y., Shibata R., Ouchi N., Kambara T., Ohashi K., Jie L., et al. Adiponectin ameliorates endotoxin-induced acute cardiac injury. BioMed Res. Int. 2014, 2014:382035.
20. Teoh H., Quan A., Bang K.W., Wang G., Lovren F., Vu V., et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E658-E664.
21. Hua Y., Xu X., Shi G.P., Chicco A.J., Ren J., Nair S. Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy. Hypertension 2013, 61:1184-1192.
22. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 2007, 100:914-922.
23. Xu X., Hua Y., Nair S., Bucala R., Ren J. Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy. Hypertension 2014, 63:490-499.
24. Zhu H., Tannous P., Johnstone J.L., Kong Y., Shelton J.M., Richardson J.A., et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J. Clin. Invest. 2007, 117:1782-1793.
25. Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004, 16:3-9.
26. Dong M., Hu N., Hua Y., Xu X., Kandadi M.R., Guo R., et al. Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3beta-dependent inhibition of apoptosis and ER stress. Biochim. Biophys. Acta 1832, 2013:848-863.
27. Zhang Y., Mi S.L., Hu N., Doser T.A., Sun A., Ge J., et al. Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function. Free Radic. Biol. Med. 2014, 71:208-220.
28. Cieslik K.A., Taffet G.E., Crawford J.R., Trial J., Mejia Osuna P., Entman M.L. AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction. J. Mol. Cell. Cardiol. 2013, 63:26-36.
29. Xu X., Bucala R., Ren J. Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy. J. Am. Heart Assoc. 2013, 2.
30. Li S.Y., Golden K.L., Jiang Y., Wang G.J., Privratsky J.R., Zhang X., et al. Inhibition of sarco(endo)plasmic reticulum Ca2+-ATPase differentially regulates contractile function in cardiac myocytes from normotensive and spontaneously hypertensive rats: role of Ca2+ regulatory proteins. Cell Biochem. Biophys. 2005, 42:1-12.
31. Iwasa T., Matsuzaki T., Matsui S., Munkhzaya M., Tungalagsuvd A., Kawami T., et al. The effects of LPS-induced endotoxemia on the expression of adiponectin and its receptors in female rats. Endocr. J. 2014.
32. Sakai S., Iizuka N., Fujiwara M., Miyoshi M., Aoyama M., Maeshige N., et al. Mild obesity reduces survival and adiponectin sensitivity in endotoxemic rats. J Surg Res. 2013, 185:353-363.
33. Kim A.S., Miller E.J., Young L.H. AMP-activated protein kinase: a core signalling pathway in the heart. Acta Physiol (Oxf.) 2009, 196:37-53.
34. Fisslthaler B., Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ. Res. 2009, 105:114-127.
35. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
36. Bjorkoy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005, 171:603-614.
37. Musumeci D., Roviello G.N., Montesarchio D. An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol. Ther. 2014, 141:347-357.
38. Niederbichler A.D., Westfall M.V., Su G.L., Donnerberg J., Usman A., Vogt P.M., et al. Cardiomyocyte function after burn injury and lipopolysaccharide exposure: single-cell contraction analysis and cytokine secretion profile. Shock 2006, 25:176-183.
39. Zhao P., Turdi S., Dong F., Xiao X., Su G., Zhu X., et al. Cardiac-specific overexpression of insulin-like growth factor I (IGF-1) rescues lipopolysaccharide-induced cardiac dysfunction and activation of stress signaling in murine cardiomyocytes. Shock 2009, 32:100-107.
40. Berg A.H., Combs T.P., Scherer P.E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol. Metab. 2002, 13:84-89.
41. Konter J.M., Parker J.L., Baez E., Li S.Z., Ranscht B., Denzel M., et al. Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation. J. Immunol. 2012, 188:854-863.
42. Masaki T., Chiba S., Tatsukawa H., Yasuda T., Noguchi H., Seike M., et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice. Hepatology 2004, 40:177-184.
43. Matsumoto H., Tamura S., Kamada Y., Kiso S., Fukushima J., Wada A., et al. Adiponectin deficiency exacerbates lipopolysaccharide/d-galactosamine-induced liver injury in mice. World J. Gastroenterol. 2006, 12:3352-3358.
44. Racioppi L., Means A.R. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J. Biol. Chem. 2012, 287:31658-31665.
45. Kondo K., Shibata R., Unno K., Shimano M., Ishii M., Kito T., et al. Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model. Circ. Cardiovasc. Interv. 2010, 3:166-173.
46. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 2005, 11:1096-1103.
47. Shibata R., Izumiya Y., Sato K., Papanicolaou K., Kihara S., Colucci W.S., et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J. Mol. Cell. Cardiol. 2007, 42:1065-1074.
48. Dong F., Ren J. Adiponectin improves cardiomyocyte contractile function in db/db diabetic obese mice. Obesity (Silver Spring) 2009, 17:262-268.
49. Ma H., Wang J., Thomas D.P., Tong C., Leng L., Wang W., et al. Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart. Circulation 2010, 122:282-292.
50. Guo R., Ren J. Deficiency in AMPK attenuates ethanol-induced cardiac contractile dysfunction through inhibition of autophagosome formation. Cardiovasc. Res. 2012, 94:480-491.
51. Zou M.H., Xie Z. Regulation of interplay between autophagy and apoptosis in the diabetic heart: new role of AMPK. Autophagy 2013, 9:624-625.
52. Ren S.Y., Xu X. Role of autophagy in metabolic syndrome-associated heart disease. Biochim. Biophys. Acta 2014.
53. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
54. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
55. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Yoshimori T., et al. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
56. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 2007, 13:619-624.
57. Cao D.J., Wang Z.V., Battiprolu P.K., Jiang N., Morales C.R., Kong Y., et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4123-4128.
58. Xie Z., Lau K., Eby B., Lozano P., He C., Pennington B., et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 2011, 60:1770-1778.
59. Xu X., Kobayashi S., Chen K., Timm D., Volden P., Huang Y., et al. Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes. J. Biol. Chem. 2013, 288:18077-18092.
60. Zou X., Xu J., Yao S., Li J., Yang Y., Yang L. Endoplasmic reticulum stress-mediated autophagy protects against lipopolysaccharide-induced apoptosis in HL-1 cardiomyocytes. Exp. Physiol. 2014.
61. Aguirre A., Lopez-Alonso I., Gonzalez-Lopez A., Amado-Rodriguez L., Batalla-Solis E., Astudillo A., et al. Defective autophagy impairs ATF3 activity and worsens lung injury during endotoxemia. J. Mol. Med. 2014, 92:665-676.
62. Carchman E.H., Rao J., Loughran P.A., Rosengart M.R., Zuckerbraun B.S. Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology 2011, 53:2053-2062.
63. Teng A.C., Miyake T., Yokoe S., Zhang L., Rezende L.M., Sharma P., et al. Metformin increases degradation of phospholamban via autophagy in cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:7165-7170.
64. Yang L., Gao J.Y., Ma J., Xu X., Wang Q., Xiong L., et al. Cardiac-specific overexpression of metallothionein attenuates myocardial remodeling and contractile dysfunction in L-NAME-induced experimental hypertension: role of autophagy regulation. Toxicol. Lett. 2015, 237:121-132.
65. Lim J.A., Li L., Kakhlon O., Myerowitz R., Raben N. Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease. Autophagy 2015, 11:385-402.
66. Moyzis A.G., Sadoshima J., Gustafsson A.B. Mending a broken heart: the role of mitophagy in cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 2015, 308:H183-H192.